CC BY-NC-ND 4.0 · Endosc Int Open 2022; 10(03): E254-E261
DOI: 10.1055/a-1672-3797
Original article

Sporadic non-ampullary duodenal adenoma with low-grade dysplasia: Natural history and clinical management

Yohei Ikenoyama
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
2   Department of Endoscopy, Mie University Graduate School of Medicine, Mie, Japan
,
Shoichi Yoshimizu
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Ken Namikawa
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Yoshitaka Tokai
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Yusuke Horiuchi
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Akiyoshi Ishiyama
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Toshiyuki Yoshio
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Toshiaki Hirasawa
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Junko Fujisaki
1   Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
› Institutsangaben

Abstract

Background and study aims Management strategies for sporadic non-ampullary duodenal adenoma with low-grade dysplasia (LGD) are not well established. This study aimed to analyze progression factors and determine suitable treatment strategies for LGD lesions.

Patients and methods We retrospectively analyzed consecutive LGD lesions (n = 125) in patients followed up for ≥ 6 months (median, 45 months) and evaluated the changes in clinicopathological features during follow-up. All LGD lesions were classified into two groups: stable LGD (no increase or < 5 mm increase in tumor size, with unchanged histological dysplasia grade) and progressive LGD (≥ 5 mm increase in tumor size and/or progression to high-grade dysplasia or adenocarcinoma).

Results Eighty-six LGD were classified as stable and 39 as progressive. Location on the oral side of the papilla of Vater, large initial tumor size ( ≥ 10 mm), macroscopically complex type, red color, and nodularity were significantly frequent in progressive LGD than in stable LGD. In multivariate analysis, large initial tumor size (odds ratio [OR], 10.2; 95 % confidence interval [CI], 3.3–32.1; P < 0.001) and location on the oral side of the papilla of Vater (OR: 1.8, 95 % CI: 1.4–12.5; P = 0.012) were significant factors for progression. Moreover, initial tumor size < 5 mm rarely progressed (0%–3.9 %); however, initial tumor size ≥ 20 mm and 10–19 mm located on the oral side of the papilla of Vater had a high-risk progression rate (75.0–85.7 %).

Conclusions According to the risk stratification of progression factors by initial tumor size and location, we can determine suitable treatment indications for LGD lesions.



Publikationsverlauf

Eingereicht: 09. Juni 2021

Angenommen: 17. September 2021

Artikel online veröffentlicht:
14. März 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Darling RC, Welch CE. Tumors of the small intestine. N Engl J Med 1959; 260: 397-408
  • 2 Hoffman BP, Grayzel DM. Benign tumors of the duodenum. Am J Surg 1945; 70: 394-400
  • 3 Shukla SK, Elias EG. Primary neoplasms of the duodenum. Surg Gynecol Obstet 1976; 142: 858-860
  • 4 Murray MA, Zimmerman MJ, Ee HC. Sporadic duodenal adenoma is associated with colorectal neoplasia. Gut 2004; 53: 261-265
  • 5 Goda K, Kikuchi D, Yamamoto Y. et al. Endoscopic diagnosis of superficial non-ampullary duodenal epithelial tumors in Japan: Multicenter case series. Dig Endosc 2014; 26: 23-29
  • 6 Takahashi T, Ando T, Kabeshima Y. et al. Borderline cases between benignancy and malignancy of the duodenum diagnosed successfully by endoscopic submucosal dissection. Scand J Gastroenterol 2009; 44: 1377-1383
  • 7 Nonaka S, Oda I, Tada K. et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy 2015; 47: 129-135
  • 8 Hoteya S, Kaise M, Iizuka T. et al. Delayed bleeding after endoscopic submucosal dissection for non-ampullary superficial duodenal neoplasias might be prevented by prophylactic endoscopic closure: Analysis of risk factors. Dig Endosc 2015; 27: 323-330
  • 9 Hoteya S, Furuhata T, Takahito T. et al. Endoscopic submucosal dissection and endoscopic mucosal resection for non-ampullary superficial duodenal tumor. Digestion 2017; 95: 36-42
  • 10 Yahagi N, Kato M, Ochiai Y. et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 2018; 88: 676-682
  • 11 Kato M, Ochiai Y, Fukuhara S. et al. Clinical impact of closure of the mucosal defect after duodenal endoscopic submucosal dissection. Gastrointest Endosc 2019; 89: 87-93
  • 12 Yamamoto Y, Yoshizawa N, Tomida H. et al. Therapeutic outcomes of endoscopic resection for superficial non-ampullary duodenal tumor. Dig Endosc 2014; 26: 50-56
  • 13 Maruoka D, Matsumura T, Kasamatsu S. et al. Cold polypectomy for duodenal adenomas: a prospective clinical trial. Endoscopy 2017; 49: 776-783
  • 14 Kiguchi Y, Kato M, Nakayama A. et al. Feasibility study comparing underwater endoscopic mucosal resection and conventional endoscopic mucosal resection for superficial non-ampullary duodenal epithelial tumor < 20 mm. Dig Endosc 2020; 32: 753-760
  • 15 Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-131
  • 16 Okada K, Fujisaki J, Kasuga A. et al. Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance. Am J Gastroenterol 2011; 106: 357-364
  • 17 Kakushima N, Ono H, Yoshida M. et al. Characteristics and risk factors for sporadic non-ampullary duodenal adenocarcinoma. Scand J Gastroenterol 2017; 52: 1253-1257
  • 18 Kawai T, Takeuchi M, Fukuzawa M. Gastric atrophy prevent from incidence of duodenal tumor?. J Clin Biochem Nutr 2017; 60: 219
  • 19 Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1: 87-97
  • 20 Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3-S43
  • 21 Kanada Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 2013; 48: 452-458
  • 22 Nunobe S, Ri M, Yamazaki K. et al. Safety and feasibility of laparoscopic and endoscopic cooperative surgery for duodenal neoplasm: a retrospective multicenter study. Endoscopy 2020; DOI: 10.1055/a-1327-5939.
  • 23 Kakushima N, Ono H, Takao T. et al. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors. Dig Endosc 2014; 26: 35-40
  • 24 Zauber AG, Winawer SJ, O'Brien MJ. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696
  • 25 Taniyama D, Taniyama K, Kuraoka K. et al. Long-term follow-up study of gastric adenoma; tumor-associated macrophages are associated to carcinoma development in gastric adenoma. Gastric Cancer 2017; 20: 929-939
  • 26 Yamada H, Ikegami M, Shimoda T. et al. Long-term follow-up study of gastric adenoma/dysplasia. Endoscopy 2004; 36: 390-396
  • 27 Kakushima N, Yoshida M, Iwai T. et al. A simple endoscopic scoring system to differentiate between duodenal adenoma and carcinoma. Endosc Int Open 2017; 5: E763-E768
  • 28 Yoshida M, Shimoda T, Abe M. et al. Clinicopathological characteristics of non-ampullary duodenal tumors and their phenotypic classification. Pathol Int 2019; 69: 398-406
  • 29 Minatsuki C, Yamamichi N, Inada KI. et al. Expression of gastric markers is associated with malignant potential of nonampullary duodenal adenocarcinoma. Dig Dis Sci 2018; 63: 2617-2625
  • 30 Ushiku T, Arnason T, Fukayama M. et al. Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol 2014; 38: 1484-1493
  • 31 Yoshimizu S, Kawachi H, Yamamoto Y. et al. Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma. J Gastroenterol 2020; 55: 754-762
  • 32 Kakushima N, Kanemoto H, Sasaki K. et al. Endoscopic and biopsy diagnoses of superficial, nonampullary, duodenal adenocarcinomas. World J Gastroenterol 2015; 21: 5560-5567